Kamal Kumar Chaudhary
Princess Pharma Pvt. Ltd, Kathmandu, Nepal
Posters & Accepted Abstracts: J Diabetes Metab
The chronic metabolic disorder diabetes mellitus is a fast growing global problem with huge social, health and economic consequences. It is estimated that in 2010 there were globally 285 million people (approximately 6.4% of the adult population) suffering from this disease. This number is estimated to increase to 430 million in the absence of better control or cure. An ageing population and obesity are two main reasons for the increase. Furthermore, it has been shown that almost 50% of the putative diabetes are not diagnosed until 10 years after onset of the disease, hence the real prevalence of global diabetes must be astronomically high. Diabetes is an important cause of prolonged ill health and premature mortality, and claims more lives per year than HIV AIDS with nearly 1 death every 10 seconds. This chapter introduces the types of diabetes and diabetic complications such as impairment of immune system periodontal disease, retinopathy nephropathy, somatic and autonomic neuropathy, cardiovascular diseases and diabetic foot. Also included are the current management and treatments, and emerging therapies.
Kamal Kumar Chaudhary has completed his Orientation Course conducted from the Department of Drug Administration for entrepreneurs of Modern Drug sale and distribution in Nepal. He is the chief executive officer of Princess Pharma Pvt. Ltd, a drug sale and distribution company. He has researched in fields such as the approach of alternative treatment of patients, introduce and implement new technological treatment methods. He is keen on importing new technological measures to treat the patients and involves himself in different seminars and conferences to stay updated on present medical technological advancement.
Email: kamalsg772@yahoo.com
